Tuesday, July 13, 2010

New Research Uncovers Why Many With Lupus Are Resistant to Traditional Treatments

Findings Could Lead to Lower Doses of Medication for Lupus Patients, Reducing Serious Side Effects

Thursday, July 1, 2010

Bold New Insurance Plan Launches

Health Coverage Now Available for Americans without Insurance Due to Pre-Existing Conditions Such as Lupus

Monday, June 28, 2010

Focus on LUPUS in Nature Reviews Rheumatology

Articles and discussions on lupus research have ushered in a new era in disease management

Friday, June 25, 2010

Human Genome Sciences Announces Presentation of Additional Phase 3 SLE Study Results for BENLYSTA® (Belimumab)

News from LUPUS 2010

Friday, June 25, 2010

Epratuzumab Data From Phase IIB EMBLEM™ Study

News from LUPUS 2010

Friday, June 18, 2010

Big Picture Data Bolsters Positive Outlook for Potential New Lupus Treatment Benlysta®

LRI hails an increasingly efficacious picture for possible first new medication for lupus in over 50 years

Wednesday, June 16, 2010

At European League Against Rheumatism Meeting 2010

New Data From EMBLEM™ Study Show Pipeline Drug Epratuzumab Provided Significant Efficacy for Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus

Thursday, June 10, 2010

Human Genome seeks FDA nod to market lupus drug

Says files Biologics License Application with FDA

Wednesday, June 9, 2010

GSK seeks EU marketing approval for lupus drug

Says to seek U.S. FDA approval by end June

Thursday, June 3, 2010

CellCept® Has Positive Results in Phase III Lupus Nephritis Trial

Maintenance phase of Aspreva Lupus Management Study (ALMS) successfully achieves primary endpoint